Discover 715 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 715
Active & Responsive
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
for
Migraine
Location: Overland Park KS, Omaha NE, St Louis MO, Rochester MN,
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70
Code: NCT06972056
Phase 4, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Lenexa KS, West Des Moines IA, Joliet IL, Lemont IL,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase 2, Phase 3, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
for
Diabetic Retinopathy, Macular Edema
Location: Lenexa KS, Plano TX, Carmel IN, Madison MS, Denver CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705555
Phase 3, Recruiting
Active & ResponsiveNew
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
for
SARS-CoV-2
Location: Overland Park KS, Prosper TX, Hendersonville TN,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT07863635
Phase 4, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
for
Preventive Treatment of Migraine
Location: Overland Park KS, Papillion NE, City of Saint Peters MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07729462
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase 1, Phase 2, Recruiting
Active & Responsive
Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin
for
Acne-prone Skin, Skin Disease
Location: Leawood KS, Tulsa OK
Sponsor: WiQo S.p.A.
Sex: All
Age: 18+
Code: NCT07866131
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Overland Park KS, Columbia MO, Wichita KS, Lincoln NE,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Overland Park KS, Kansas City KS, Kansas City MO,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)
for
Flexible Hammertoe, Semi-flexible Hammertoe
Location: Overland Park KS, Springfield IL, Bedford TX,
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Sex: All
Age: 18 - 70+
Code: NCT07759362
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Kansas City MO, Topeka KS, Columbia MO, St Louis MO,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Kansas City MO, Topeka KS, Columbia MO, St Louis MO,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: Leawood KS, Wichita KS, Oklahoma City OK,
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
Head Positioning After Retina Detachment Repair
for
Retina; Detachment, Rhegmatogenous
Location: Prairie Village KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03714503
Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Fairway KS, Lincoln NE, St Louis MO, Dallas TX,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase 3, Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Fairway KS, Columbia MO, Omaha NE, Peoria IL,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
SynKIR-310 for Relapsed/Refractory B-NHL
for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: Fairway KS, Denver CO, Atlanta GA, Philadelphia PA,
Sponsor: Verismo Therapeutics
Sex: All
Age: 18+
Code: NCT06544265
Phase 1, Recruiting
Active & Responsive
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
for
Congenital Myotonic Dystrophy, CDM
Location: Fairway KS, Rochester NY, Richmond VA, Los Angeles CA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 0 - 4
Code: NCT05224778
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Westwood KS, St Louis MO, Iowa City IA, Rochester MN,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Kansas City KS, Topeka KS, Hannibal MO, McKinney TX,